




Michael J. Landine - Director at Alkermes, Inc.



























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology








            You have  
            
9 free profiles

              left this month   
			      

                Start Your Free Trial ➤
              








            Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there?
            

                View on RelSci Pro ➤
              




























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink





Michael J. Landine
Director at Alkermes, Inc.



Overview
Relationships Paths
Education Career History Boards & Committees Public Holdings Awards & Honors 


Michael J. Landine
Director at Alkermes, Inc.



 Overview



Age



63
                                  (Born 1954)
                                              




Notable Companies


Walker Magnetics Group, Inc.




Awards



1





Board Seats



4





Number of Relationships



                This person is connected to 220 people.
              






 Relationships
              See Details




Michael A. Wall

Founder at Alkermes, Inc.




James M. Frates

Senior Vice President, Chief Financial Officer & Treasurer at Alkermes Plc





John C. C. Fan

Founder at Kopin Corp.




Richard Pops

Chief Executive Officer at Alkermes Plc





Kathryn L. Biberstein

Executive Vice President, Chief Compliance Officer & Chief Administrative Officer at Alkermes, Inc.




Mark B. Skaletsky

Chairman & Chief Executive Officer at Fenway Pharmaceuticals, Inc.





Floyd Bloom

Medical & Scientific Advisor at NeuroVentures Capital LLC




Robert A. Breyer

Former President at Alkermes, Inc.





Paul J. Mitchell

President at Mitchell Financial Group




Mitchel Sanders

Founder at Expressive Constructs, Inc.







See 210 more listings with RelSci Professional.

Start My Free Trial ➤








See 210 More 


 


 Paths to Michael J. Landine



            Michael J. Landine          




 You



 Connections via Relationship Science



 Michael J. Landine






Sync your contacts to see how you can connect with Michael J. Landine.

Start My Free Trial ➤








See  More 


 


 Educational Background



Bachelor of Science Degree in Accounting 


Bentley University

                  Bentley University is one of the nation's leading business schools, dedicated to preparing a new kind of business leader and one with the deep technical skills, the broad global perspective and the high ethical standards required to make a difference in an ever-changing world.                





 Career History



Director

                                    1988 - Current                


Alkermes, Inc.


                  Alkermes, Inc. develops and manufactures pharmaceutical products. It offers Risperdal Consta, atypical antipsychotic medication approved for use in schizophrenia and Vivitrol, being developed as a once-monthly injection for the treatment of alcohol dependence. The company was founded by Michael Wall, Floyd Bloom, Frederick W. K. Brown, Paul Schimmel, and Alexander Rich on July 13, 1988 and is headquartered in Waltham, MA.                




Senior Vice President, Corporate Development

                                    1988 - Current                


Alkermes Plc


                  Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.                




Professional

                                    Prior                


Touche Ross & Company


                  Touche Ross & Co. is a public accounting firm and is now Deloitte
& Touche LLP.                




Chief Financial Officer

                                    Prior                


Walker Magnetics Group, Inc.


                  Walker Magnetics Group, Inc. manufactures magnetic material handling systems, conveying systems, magnetic conveying components, and other magnetic tools. It sells replacement components for magnetic conveying equipment. The company was founded by Oakley S. Walker in 1896 and is headquartered in Worcester, MA.                





 Boards & Committees



Corporate Boards ▾




Member, Board of Directors

                    2003 - Current                  


Kopin Corp.

                    Kopin Corp. invents, develops, manufactures and sells wearable technologies which include components and systems. Its portfolio includes ultra-small displays, optics, speech enhancement technology system, and hands-free control software, low-power ASICs, and smart headset reference systems. It uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. Kopin was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.                  




Director

                    1988 - Current                  


Alkermes, Inc.

                    Alkermes, Inc. develops and manufactures pharmaceutical products. It offers Risperdal Consta, atypical antipsychotic medication approved for use in schizophrenia and Vivitrol, being developed as a once-monthly injection for the treatment of alcohol dependence. The company was founded by Michael Wall, Floyd Bloom, Frederick W. K. Brown, Paul Schimmel, and Alexander Rich on July 13, 1988 and is headquartered in Waltham, MA.                  




Director

                    Prior - 2013                  


Expressive Constructs, Inc.

                    Expressive Constructs, Inc. researches and develops antibody detection technologies. The company's products include diagnostic sensor for urinary tract infections and wound care systems that provide warning of emergent infections and promote healing. It was founded by Mitch Sanders in 1998 and is headquartered in Worcester, MA.                  




Director

                    2004 - 2012                  


rEVO Biologics, Inc.

                    rEVO Biologics, Inc. develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. it produced a product named ATryn for recombinant protein production. The company was founded in February, 1993 and is headquartered in Framingham, MA.                  





 Public Holdings






Restricted data only for RelSci Professional users.

Start My Free Trial ➤








See  More 


 


 Awards & Honors




                  Professional Certification                




CPA (Certified Public Accountant)

                                    Sponsored by
                  American Institute of Certified Public Accountants






 Other Affiliations




              Michael J. Landine is affiliated with
                            Alkermes, Inc., Alkermes Plc, Touche Ross & Company, Walker Magnetics Group, Inc., Kopin Corp., Alkermes, Inc., Expressive Constructs, Inc., rEVO Biologics, Inc..
            





You've reached your 10 free profiles limit this month.
Upgrade to RelSci Pro today to enjoy unlimited article views and much more!

Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.












Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤
















Michael J Landine - West Dennis, MA | Intelius



























Sign In



We found Michael J Landine in West Dennis, MA


Michael J Landine

                                                                           Intelius found that Michael J Landine  is  a male between 60 and 70 years old from West Dennis, MA.  We have connected them to
                5 addresses,
                9 phones,
                and 3 relatives or associates.
         





Also Known As

Michael P Landine


Get Report Now

Age

Michael J Landine is in his 60s

Michael Has Lived In

West Dennis, MA
Taunton, MA
Cambridge, MA

Michael's Relatives

Megan Landine
Andrea Landine
Patricia Landine







Michael J Landine



Zodiac SignCapricorn



GenderMale



Professional Status
Director at Kopin Corporation



Get Report Now










Want to know more about Michael? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Michael, or use our people search engine to find others.
Get Background Check on Michael J Landine
Get a Criminal Check on Michael J Landine
Get a Public Record Report on Michael J Landine
Get a People Search Report on Michael J Landine


Michael J Landine's Contact Information
Known Cities Lived In
Find out where Michael J Landine has lived as well as Michael J Landine's phone numbers and email addresses.




Michael J Landine Has Lived in 1 States
Massachusetts Address for Michael J Landine


63 S V****** R* 

West Dennis, MA


Has Lived In

West Dennis, MA
Taunton, MA


Get Full Address Report










Phone Numbers Associated with Michael J Landine

(508) ***-**** - West Dennis, MA 
(508) ***-**** - Shrewsbury, MA 
(617) ***-**** - Cambridge, MA 


Get Full Phone Report



Email Addresses Associated with Michael J Landine

a*****1@***.com
m******e@***.com
m******e@***.com


Get Email Report




Michael J Landine's Professional Information
Information regarding Michael J Landine's professional history.  Find out previous places Michael J Landine has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Michael J Landine Has Worked at 11 Places
Company: Kopin Corporation
               Title: Director
Company: Alkermes
               Title: Vice President
Michael J Landine's Experience
Title: Director
               Company: Kopin Corporation
Job Details
               Company Size: $25 mil to less than $50 mil - Employee Range: 100 to less than 500
Title: Vice President
               Company: Alkermes
Job Details

Additional Professional Information on Michael J Landine

 See Michael J Landine's LinkedIn Profile



Michael J Landine's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Michael J Landine


Michael J Landine's known Social Networks And Potential Email Matches

Find all of Michael J Landine's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Michael Landine
Username Matches

                  MichaelLandine
                  LandineMichael
                  Michael.Landine
                  Landine.Michael
                  Michael_Landine
                  Landine_Michael
                  Michael-Landine
                  Landine-Michael
                  MLandine
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
M Landine







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.














KOPN Michael J. Landine Insider Trades for Kopin Corp.


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Kopin Corp.

                  NASDAQ: KOPN
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Kopin Corp.



After Hours
 --Quotes are delayed by 20 min
Jul 21, 2017, 4:33 p.m.


KOPN

/quotes/zigman/74426/composite


$
4.03




Change

-0.0008
-0.02%

Volume
Volume 210,613
Quotes are delayed by 20 min








/quotes/zigman/74426/composite
Previous close

$
			4.12
		


$
				4.03
			
Change

-0.09
-2.18%





Day low
Day high
$4.01
$4.20










52 week low
52 week high

            $1.93
        

            $4.49
        


















Insider Activity


Individual




Michael J. Landine



Mr. Michael J. Landine, CPA, is Senior Vice President-Corporate Development at Alkermes Plc and Independent Director at Kopin Corp. He is on the Board of Directors at Kopin Corp.
Mr. Landine was previously employed as Senior Vice President-Corporate Development by Alkermes, Inc. and Chief Financial Officer by Walker Magnetics Group, Inc. He also served on the board at GTC Biotherapeutics, Inc. and Expressive Constructs, Inc.
He received his undergraduate degree from Bentley University.



Transactions


Date
Shares
Transaction
Value





05/31/2017
10,000


 
Award at $0 per share.


0


05/17/2016
15,000


 
Acquisition at $1.77 per share.


26,550


05/17/2016
10,000


 
Acquisition at $1.79 per share.


17,900


05/11/2016
10,000


 
Award at $0 per share.


0


05/18/2015
142


 
Disposition at $3.75 per share.


533


05/18/2015
142


 
Derivative/Non-derivative trans. at $3.5 per share.


497


05/08/2015
10,000


 
Award at $0 per share.


0


04/29/2014
10,000


 
Award at $0 per share.


0


05/09/2013
10,000


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. John C. C. Fan 
Chairman, President & Chief Executive Officer




Mr. Richard A. Sneider 
Chief Financial Officer & Treasurer




Dr. Hong K. Choi 
Chief Technology Officer & Vice President




Mr. Bill  Maffucci 
Vice President & GM-Government Programs




Mr. Harry  Buchanan 
Director-Business Development




Dr. Bor-Yeu  Tsaur 
Executive Vice President-Display Operations




Mr. David E. Brook 
Secretary & Director




Mr. Stuart  Nixdorff 
Senior Vice President-Sales & Marketing




Mr. Jim K. Brewington 
Independent Director




Mr. Andrew H. Chapman 
Independent Director




Dr. Mort C. Collins 
Lead Independent Director




Dr. Chi Chia  Hsieh 
Independent Director




Mr. Michael J. Landine 
Independent Director
















Log In




3:10 AM EDT
July 23, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
5:12pTrump says he has ‘complete power to pardon’
5:08pLawmakers reach deal on Russia sanctions bill: reports
5:00pAlphabet earnings: A $2.74 billion hit for Google, potential YouTube results for investors
3:30pYou can date someone who looks just like Donald Trump with this new online service 
3:29pWant to buy happiness? Splurge on these 5 things
3:28pThis is what people really buy when they emotionally overspend (hint: it’s not designer clothes)
2:40pJohn McCain is a war hero — but think twice before saying he’s ‘battling’ cancer 
2:38pThe dark side of cruises
2:37pI want to buy my brothers out of our family home — but they want me to pay (future) sales fees
2:35pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
2:34pNot even free money can make some people go to the gym 
2:34pHow real-estate TV shows determine what buyers look for in a house
2:34pWhat Eleanor Roosevelt and Helen Gurley Brown ate — and what we can learn from it 
2:33pNote to parents: This social network was rated the worst for teenage cyberbullying
2:33pIf, like Sean Spicer, you suddenly quit your job — what should you do next?
2:32pThis is the deadliest time of your life to put on weight
2:32p5 unfortunate reasons why millennials can’t have nice things (or save any money)
2:26pU.S. giving takeover bids by Chinese firms much tougher look
1:13pJared Kushner discloses dozens of additional assets in revised filing
12:51pBitcoin surges as miners avert split for now
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































   Michael Landine | Alkermes , Inc. | ZoomInfo.com










 


Michael J. Landine, Board Dir., Expressive Constructs Inc.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of Michael Landine 





 


Michael Landine

 

Board Dir. - Expressive Constructs Inc.

 


Michael Landine Email :
Please login 

 

Company Name : 
Expressive Constructs Inc. 

 

Company Website : 
www.ecibiotech.com 

 

Company Address : 
85 Prescott St., Worcester, MA,United States, 


 


Michael Landine Profile :
Board Dir. - Expressive Constructs Inc. 

 


Michael Landine Biography :


Mike Landine has served as Vice President, Corporate Development of Alkermes since March 1999. From March 1988 until June 1998, he was Chief Financial Officer and Treasurer of Alkermes. Mike is also currently an advisor to Walker Magnetics Group, an international manufacturer of industrial equipment and is a member of the Board of Directors of Kopin Corporation, a developer and manufacturer of compound semiconductor components and miniature flat panel displays for use in wireless and consumer electronic products. Mike received a B.S. in Accounting from Bentley College and is a Certified Public Accountant. 

 


Michael Landine Colleagues :





Name 
Title 
Email 


Anthony Bernardo 
Dir., Pres., CEO 
Please login 


Mitch Sanders 
Dir., Exec. VP, Founder 
Please login 


Duane James 
CFO 
Please login 


James Comolli 
Dir. - Research, Development 
Please login 


Diane Busby 
Principal Sciencist 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

� 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.





Michael J. Landine: Executive Profile & Biography - Bloomberg









































  





















































































July 23, 2017 3:10 AM ET
Biotechnology

Company Overview of Alkermes plc



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Michael J. Landine  Senior Vice President of Corporate Development, Alkermes plcAgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.See Board Relationships63--
Background

		Mr. Michael J. Landine, also known as Mike, Founded Genomics Collaborative, Inc. Mr. Landine has been a Senior Vice President of Corporate Development of Alkermes plc since September 16, 2011. He serves as an Advisor of Walker Magnetics Group. He served as Senior Vice President of Corporate Development at Alkermes, Inc. from May 2007 to September 16, 2011 and served as its Vice President of Corporate Development from March 1999 to May 22, 2007. From March 1988 to June ... 1998, Mr. Landine served as Chief Financial Officer and Treasurer of Alkermes, Inc., where he worked for over 20 years. From 1976 to 1983, Mr. Landine worked for the international accounting firm Touche Ross & Co. He has been a Director at Kopin Corporation since 2003. He served as a Director of Genomics Collaborative, Inc. He serves on the Board of Directors of Expressive Constructs, Inc. He served as an Independent Director of GTC Biotherapeutics Inc. from December 2004 to December 2010. He was previously a Certified Public Accountant. Mr. Landine received a B.S. in Accounting from Bentley College.Read Full Background




Corporate Headquarters
Connaught HouseDublin, Co. Dublin 4IrelandPhone: 353 1 772 8000Fax: --
Board Members Memberships
DirectorExpressive Constructs, Inc.2003-PresentDirectorKopin Corporation
Education
BS Bentley University
Other Affiliations
Genomics Collaborative, Inc.rEVO Biologics, Inc.Kopin CorporationBentley UniversityExpressive Constructs, Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationDame Louise Makin MA, Ph.D.(Cantab), MBA, DBEChief Executive Officer & Executive DirectorBTG plc$1.5MErik  Bogsch Chairman, Chief Executive Officer, Managing Director and Member of Executive BoardRichter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.--Vinita D. Gupta CEO & Executive Director Lupin Limited$173.7MLeon O. Moulder Jr., M.B.A.Co-Founder, Chief Executive Officer and DirectorTesaro, Inc.$639.4KShaun  Thaxter Chief Executive Officer and Executive DirectorIndivior PLC$2.2MCompensation as of Fiscal Year 2017.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Alkermes plc, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close

























































Insider Selling: Alkermes PLC (ALKS) Director Sells 1,500 Shares of Stock - American Banking News




















































Home
Get Email Updates
About
Disclaimer
Contact
Privacy Policy









 
			

















Business News
U.S. News
World News
Stock Ratings

Analysts' Upgrades
Analysts' Downgrades
Analysts' EPS Estimates
Analysts' Price Targets
Analysts' New Coverage


Corporate Earnings

Earnings Results
Earnings Guidance
Earnings Previews


Dividends
Insider Trades
Options
Press Releases






















Alkermes PLC - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for Alkermes PLC with our FREE daily email newsletter:



 











 Recent Stories


Credit Suisse Group AG Reaffirms “Outperform” Rating for Zpg Plc (ZPLA)


HSBC Holdings plc Reiterates Buy Rating for Pennon Group plc (PNN)


Moneysupermarket.Com Group PLC (MONY) Rating Reiterated by Barclays PLC


Prudential plc (LON:PRU) Stock Rating Reaffirmed by Barclays PLC


Inmarsat Plc (ISAT) PT Lowered to GBX 830 at HSBC Holdings plc


South32 Ltd (LON:S32) Rating Reiterated by Barclays PLC


Credit Suisse Group AG Reaffirms “Underperform” Rating for National Grid plc (NG)


United Utilities Group PLC (UU) Price Target Cut to GBX 1,000


Dixons Carphone PLC (LON:DC) Given “Outperform” Rating at Credit Suisse Group AG


Tullow Oil plc’s (TLW) “Overweight” Rating Reiterated at Barclays PLC


Severn Trent Plc (LON:SVT) Earns Hold Rating from HSBC Holdings plc


easyJet plc (LON:EZJ) PT Raised to GBX 1,600


KCOM Group PLC (LON:KCOM) Given Buy Rating at Peel Hunt


Enquest Plc (ENQ) Earns “Underweight” Rating from Barclays PLC


Premier Oil PLC (LON:PMO) Rating Reiterated by Barclays PLC


Analyzing DNIB Unwind (BIND) and Anavex Life Sciences Corp. (AVXL)


Comparing Callaway Golf (ELY) & Johnson Outdoors (JOUT)


Comparing Bankrate (NYSE:RATE) & IHS Markit (INFO)


Patterson Companies (PDCO) vs. Merit Medical Systems (MMSI) Head-To-Head Contrast


Financial Comparison: Crane (CR) and SPX Corporation (NYSE:SPXC)





 






						Insider Selling: Alkermes PLC (ALKS) Director Sells 1,500 Shares of Stock					

July 6th, 2017  • 0 comments • Filed Under •
 by ABMN Staff



							Filed Under: Insider Trades • Market News 






Tweet










Alkermes PLC (NASDAQ:ALKS) Director Paul J. Mitchell sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $58.11, for a total value of $87,165.00. Following the completion of the sale, the director now owns 9,500 shares of the company’s stock, valued at $552,045. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 
Shares of Alkermes PLC (NASDAQ ALKS) traded down 1.62% during mid-day trading on Thursday, hitting $59.47. The stock had a trading volume of 1,555,840 shares. The company’s market cap is $9.11 billion. The stock has a 50 day moving average price of $58.44 and a 200-day moving average price of $57.27. Alkermes PLC has a 52-week low of $41.93 and a 52-week high of $63.40. 


 Get Alkermes PLC alerts:



Alkermes PLC (NASDAQ:ALKS) last released its quarterly earnings data on Thursday, April 27th. The company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.07. Alkermes PLC had a negative net margin of 25.61% and a negative return on equity of 9.76%. The firm had revenue of $191.80 million during the quarter, compared to analysts’ expectations of $195.79 million. During the same period in the previous year, the business earned ($0.16) earnings per share. The business’s revenue for the quarter was up 22.3% on a year-over-year basis.  On average, equities analysts expect that  Alkermes PLC will post ($0.04) earnings per share for the current fiscal year. 
TRADEMARK VIOLATION WARNING: “Insider Selling: Alkermes PLC (ALKS) Director Sells 1,500 Shares of Stock” was first  posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/07/06/insider-selling-alkermes-plc-alks-director-sells-1500-shares-of-stock-2.html. 




A number of institutional investors have recently added to or reduced their stakes in the stock. First Quadrant L P CA purchased a new position in  Alkermes PLC during the first quarter valued at $3,704,000.  First Citizens Bank & Trust Co. purchased a new position in  Alkermes PLC during the first quarter valued at $730,000.  Acadian Asset Management LLC increased its position in  Alkermes PLC by 545.9% in the first quarter. Acadian Asset Management LLC now owns 33,438 shares of the company’s stock valued at $1,956,000 after buying an additional 28,261 shares during the last quarter.  Mn Services Vermogensbeheer B.V. increased its position in  Alkermes PLC by 5.9% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 4,053 shares of the company’s stock valued at $222,000 after buying an additional 224 shares during the last quarter.  Finally, Roanoke Asset Management Corp NY increased its position in  Alkermes PLC by 17.6% in the first quarter. Roanoke Asset Management Corp NY now owns 82,591 shares of the company’s stock valued at $4,832,000 after buying an additional 12,349 shares during the last quarter. 97.75% of the stock is owned by hedge funds and other institutional investors. 
A number of analysts have recently commented on ALKS shares. J P Morgan Chase & Co  set a $78.00 price objective on Alkermes PLC and gave the company a “buy” rating in a research report on Thursday, April 27th. Cowen and Company  reaffirmed a “positive” rating and issued a $65.00 price target on shares of Alkermes PLC in a research note on Tuesday, March 21st. Cantor Fitzgerald  reaffirmed a “neutral” rating and issued a $51.00 price target on shares of Alkermes PLC in a research note on Thursday, March 16th. Jefferies Group LLC  reaffirmed a “buy” rating and issued a $70.00 price target on shares of Alkermes PLC in a research note on Monday, April 3rd. Finally, Credit Suisse Group  reaffirmed a “buy” rating and issued a $70.00 price target on shares of Alkermes PLC in a research note on Wednesday, June 7th. Six equities research analysts have rated the stock with a hold rating and five have assigned  a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $63.10.
Alkermes PLC Company Profile
Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS).





Receive News & Ratings for Alkermes PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alkermes PLC and related companies with MarketBeat.com's FREE daily email newsletter.



 































Leave a Reply

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be placed in moderation!











			© Copyright American Banking and Market News 2006-2017. All rights reserved. 

Privacy Policy and Disclosures |
			About | Advertising 
			| Contact







Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.


















































Michael J. Landine - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Michael J. Landine
Senior Vice President, Corporate Development at Alkermes


View Full Profile
Are you Michael J. Landine? Claim your profile


 


Sign up for Equilar Atlas and view Michael J. Landine's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Michael J. Landine's  network and community.
												FOLLOW changes in Michael J. Landine's employment and money-in-motion.
												CONNECT with Michael J. Landine through your network of contacts.
												








Michael J. Landine's Executive Work History


Current


Senior Vice President, Corporate Development, 
Alkermes


Past
To view Michael J. Landine's complete executive work history, sign up now
Education


														 B.S., 
															Bentley College


Age
63

 
 


Michael J. Landine's Biography




			Mr. Landine has served as one of our directors since 2003. Mr. Landine is Senior Vice President of Corporate Development of Alkermes, Inc., where he has worked for over 20 years. Mr. Landine served for 10 years as the Chief Financial Officer and Treasurer of Alkermes. Mr. Landine worked for the international accounting firm Touche Ross & Co. During the past five years Mr. Landine has not served on the board of directors of any other public companies or registered management investment companies other than GTC Biotherapeutics Inc., a publicly-traded biotechnology company.
		
Source: Kopin Corporation on 07/21/2011
		
	

 






Sign up for Equilar Atlas and view Michael J. Landine's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Michael J. Landine. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Michael J. Landine's  network and community.
												FOLLOW changes in Michael J. Landine's employment and money-in-motion.
												CONNECT with Michael J. Landine through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Michael J. Landine


















Michael J. Landine's Connections (68)





Sign up now to view Michael J. Landine's 68 connections »









Geoffrey F. Cox
Dir. and Former Interim Chief Executive Officer, Novelion Therapeutics Inc.









John K. Clarke
Former Board Member, Alnylam Pharmaceuticals, Inc.









David W. Anstice
Former Executive Vice President, Strategy Initiatives, Merck & Co (Old)









James L. Wright
Former Senior Vice President, Pharmaceutical Research and Development, Alkermes









Bor-Yeu Tsaur
Executive Vice President, Display Operations, Kopin Corporation









Gordon G. Pugh
SVP, COO & CRO, Alkermes, Inc., Alkermes









Richard F. Pops
Chairman of the Board and Chief Executive Officer, Alkermes









Daily S. Hill
Former Senior Vice President, III-V Operations, Kopin Corporation









Rebecca J. Peterson
Former Senior Vice President, Corporate Communications, Alkermes









Robert A. Breyer
Board Member, Alkermes








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









David J. O'Connor
President and CEO, The Madison Square Garden Company









Claiborne P. Deming
Chairman of the Board, Murphy Oil Corporation












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
















Alkermes PLC (ALKS) SVP Michael J. Landine Sells 10000 Shares



























 
							Sunday, 23 July 2017							
							

About Us 
 
Contact Info 
Advertising 








 

 




Latest news

Highland Capital Management LLC Has $650000 Position in Ball Corporation (BLL)
$0.11 EPS Expected for Applied Genetic Technologies Corporation (NASDAQ:AGTC) This Quarter
The Potbelly Corporation (PBPB) Cut to "C" at TheStreet
'Big Brother 19' Veto Ceremony is held, replacement nominee named




Main » Alkermes PLC (ALKS) SVP Michael J. Landine Sells 10000 Shares


Alkermes PLC (ALKS) SVP Michael J. Landine Sells 10000 Shares
16 June 2017



Alkermes PLC (NASDAQ:ALKS) insider Shane Cooke sold 10,000 shares of the business's stock in a transaction on Thursday, June 8th. The stock declined 3.54% or $2.18 reaching $59.48 per share. Alkermes Plc now has $9.32 billion valuation. Alpha One also assigned news coverage about the company an impact score of 42 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.Shares of Alkermes PLC (NASDAQ ALKS) traded up 1.47% during midday trading on Wednesday, hitting $59.47.The stock of Atara Biotherapeutics Inc (NASDAQ:ATRA) is a huge mover today! About 537,764 shares traded. Cellectar Biosciences Inc (NASDAQ:CLRB) has risen 63.81% since June 12, 2016 and is uptrending. It has outperformed by 30.80% the S&P500.The move comes after 8 months negative chart setup for the $9.23B company. It was reported on Jun, 12 by Barchart.com.


Esha Deol and Bharat Takthani are off to Greece for Babymoon!
And before the mom-to-be enters her third trimester, she made a decision to go on a babymoon with husband. And among the list of ladies, who will soon be mommies, is Hema-Dharmendra's darling daughter Esha Deol .
The stock decreased 3.01% or $0.5 on June 9, reaching $16.11. Its down 0.29, from 1.2 in 2016Q3. The correct version of this piece can be read at https://www.thestockobserver.com/2017/06/14/alkermes-plc-alks-svp-michael-j-landine-sells-10000-shares-of-stock-updated-updated-updated.html. 138.80 million shares or 2.08% more from 135.97 million shares in 2016Q3 were reported. Allianz Asset Mngmt Ag reported 166,631 shares. FMR LLC boosted its position in shares of Alkermes PLC by 0.4% in the first quarter.Alkermes PLC (NASDAQ:ALKS) last announced its quarterly earnings results on Thursday, April 27th. Kanaly Trust Commerce reported 0% of its portfolio in Alkermes Plc (NASDAQ:ALKS). Neuberger Berman Gp Limited Liability Co reported 0% stake. Us Savings Bank De has invested 0% of its portfolio in Alkermes Plc (NASDAQ:ALKS). Invesco Ltd reported 5.31 million shares. After $-0.31 actual earnings per share reported by Alkermes Plc for the previous quarter, Wall Street now forecasts -16.13% EPS growth. Goldman Sachs Group Inc. increased its stake in Alkermes PLC by 40.3% in the first quarter. 254,590 were accumulated by Scout. Voya Inv, a Georgia-based fund reported 62,913 shares. Frontier Mngmt Communication Limited Company invested in 942,034 shares. Point72 Asset Management L.P. boosted its position in Alkermes PLC by 196.4% in the first quarter. Exane Derivatives holds 0% or 10,396 shares in its portfolio. Commonwealth Natl Bank Of holds 921 shares.Analysts await Alkermes Plc (NASDAQ:ALKS) to report earnings on July, 27. Alkermes had 17 analyst reports since September 1, 2015 according to SRatingsIntel. Finally, TheStreet raised shares of Alkermes Plc from a d+ rating to a c rating in a research note on Wednesday, February 15th. The firm earned "Overweight" rating on Friday, July 29 by Barclays Capital. Cowen and Company restated a "buy" rating on shares of Alkermes PLC in a research report on Friday, April 28th. The firm has "Outperform" rating by Leerink Swann given on Friday, October 21. On Friday, October 21 the stock rating was upgraded by JP Morgan to "Overweight". As per Tuesday, September 1, the company rating was upgraded by Morgan Stanley. The firm has "Outperform" rating by Leerink Swann given on Thursday, January 21. The rating was initiated by Macquarie Research with "Neutral" on Friday, August 26. Greenwood Capital Associates LLC acquired a new position in Alkermes PLC during the fourth quarter valued at approximately $202,000.
Senior member of Islamic State-backed Maute group arrested: Philippines
Police said the suspected bomber used a fake student ID of Mindanao State University with the name Alfaiz P.   Another member of the Maute clan was arrested by government forces on Thursday.
In related news, Director Paul J. Mitchell sold 1,500 shares of the company's stock in a transaction on Thursday, June 1st.Investors sentiment increased to 0.97 in 2016 Q4. Its up 0.38, from 1.48 in 2016Q3. State Of Wisconsin Invest Board invested 0.02% in Alkermes Plc (NASDAQ:ALKS). 11 funds opened positions while 30 raised stakes. Sg Americas Limited Liability Company accumulated 32,145 shares. Cullinan Associate owns 48,000 shares. Meeder Asset Mgmt holds 188,618 shares or 0.54% of its portfolio. Dimensional Fund Ltd Partnership stated it has 21,797 shares. Primecap Mngmt Com Ca has invested 0.35% in Alkermes Plc (NASDAQ:ALKS). 889.22 million shares or 2.82% less from 915.05 million shares in 2016Q3 were reported.A number of hedge funds have recently bought and sold shares of the stock. Van Eck Assocs holds 0.05% or 183,239 shares in its portfolio. Gideon Cap Advsrs holds 0.34% or 9,673 shares in its portfolio. Great West Life Assurance Can has invested 0% in Atara Biotherapeutics Inc (NASDAQ:ATRA).
Scotland can still qualify - Strachan
The Celtic left-back was moved to right-back for the 1-0 World Cup qualifying win against Slovenia at the national stadium in March.
Since January 1, 0001, it had 0 insider buys, and 2 sales for $1.73 million activity. Kelly Lawrence W And Inc Ca stated it has 45,000 shares or 0.55% of all its holdings. 2,500 shares were sold by Soffer Gad, worth $50,000. Hudson Valley Investment Advisors Adv has 15,423 shares. Clark Mitchall G. sold $48,822 worth of stock or 3,059 shares. Six investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Thomson Reuters had 15 analyst reports since July 29, 2015 according to SRatingsIntel. UBS Group AG now owns 160,616 shares of the company's stock worth $7,553,000 after buying an additional 75,559 shares in the last quarter. Finally, Jefferies Group LLC restated a "buy" rating and set a $70.00 target price on shares of Alkermes PLC in a research report on Monday, April 3rd. The rating was maintained by Barclays Capital with "Equal-Weight" on Tuesday, August 23. The company has market cap of $491.82 million.




Related articles




US Fed interest rate hikes keep coming


Cosby's fate rests with jury in Pennsylvania sex assault case




EU door remains open, France's Macron tells Theresa May


UK to hold inquiry after London tower fire claims 17




CBI probes cheating in AIIMS MBBS entrance exam, conducts raids


How Analysts Rated Canadian Pacific Railway Limited (USA) (NYSE:CP) Last Week?




Agent injured in shooting throws first pitch at congressional baseball game




Liverpool consider sending Joe Gomez out on loan


Albany Molecular Research, Inc. (AMRI) Downgraded by William Blair to Market Perform




Georgia Special Election Attracts Unusual Attention From Voters




Share !


 



Previous: Georgia Special Election Attracts Unusual Attention From Voters
Next: Trump hits back over 'obstruction of justice' claims







 Advertising
 


 


More news	






U.S.  lawmakers back at work after shooting, congressman still hospitalized


Trump Responds to WashPo Obstruction of Justice Bombshell: 'Phony Story. Nice'


Trump attacks obstruction of justice probe by former FBI chief Mueller





Qatar signs pact with U.S.  to buy F-15 jets





UK's May Uses Downing Street Back Entrance After Election Debacle





Gene Simmons Files for Trademark on Devil Horn Hand Gesture


(UPDATE) India to play Pakistan in Champions Trophy final


Opko Health, Inc. (OPK) Director Buys 10000 Shares of Stock





Maclin catches on with Ravens after unexpected exit from KC


Curry, Durant committed to Golden State


Congressional Baseball Game played day after shooting at practice


Albemarle Corporation (NYSE:ALB) Has Decline in Shorts


Trump hits back over 'obstruction of justice' claims


India beat Bangladesh to reach final





Trump responds to report that he's being investigated for obstruction of justice



 






 






	
    Copyright © 2017 HealthcareMenu |     All rights reserved.

	
		














